Integrated Solutions for Sophisticated Diagnostic Products

arvato services healthcare has taken on global logistics for Berlin-based Epigenomics AG’s cancer diagnostic products.

The international outsourcing and logistics services provider will distribute a wide range of medical products for the molecular diagnostics company from its base in Monheim to laboratories and scientific institutions. In addition, arvato will provide packaging, in- and outbound transport, storage logistics services and refrigerated logistics.

Epigenomics’ product portfolio includes innovative laboratory tests for early detection and diagnosis of intestinal, lung and prostate cancer.

Appropriate refrigeration and safety specifications must be adhered to when shipping and transporting diagnostic products - arvato services healthcare has therefore focused on developing its expertise in this area at its site in Monheim on the Rhine, and over the last five years the number of shipments in this sector has tripled.

Quality assurance measures are always a top consideration: “Safe handling can only be ensured if we keep abreast of the changing legal stipulations. All our employees working with temperature-sensitive and sophisticated diagnostic products undergo regular specialist training programs to meet these demands,” explains André Sieberling, director of the Monheim site.

In addition to arvato’s expertise in diagnostics, Epigenomics’ decision to work with arvato services healthcare centred on its high safety standards, the broad spectrum of services offered and Monheim’s scalability. “When awarding the contract we consciously chose a service provider with a flexible distribution network that can grow with increasing demand,” emphasizes Dr. Uwe Staub, Senior Vice President of Product Development at Epigenomics. “Because arvato takes on all the global distribution processes,” points out Dr. Thorsten Winkelmann, President of arvato services healthcare, “the customer can concentrate fully on its core business.”

Epigenomics employs just under 90 people in Germany and is also represented in the United States by a subsidiary in Seattle, Washington.

About Epigenomics

Epigenomics AG (Frankfurt Prime Standard: ECX) is a molecular diagnostics company emphasizing the development of novel cancer diagnostic products. Using DNA methylation biomarkers, Epigenomics’ tests aim, on the market and during development, to diagnose cancer in the early stages before symptoms occur, and could thereby reduce the mortality rate of this dreaded disease.

Epigenomics’ product portfolio encompasses the CE-marked IVD test Epi proColon, the world’s first molecular diagnostic test developed according to IVD regulations for detecting intestinal cancer via a blood test, which is based on the Septin9 biomarker, and Epi proLung, an innovative IVD test for the diagnosis of lung cancer, as well as other DNA methylation biomarkers and IVD products proprietary to the company in different states of development for intestinal, lung and prostate cancer. For the development and global marketing of in vitro diagnostic test kits, Epigenomics follows a dual business model in which direct marketing of its own diagnostic test products is combined with a non-exclusive licensing strategy for diagnostics providers with access to a broad range of customers. Epigenomics’ strategic partners in the diagnostics industry include Abbott Molecular, Inc., Sysmex Corporation, Quest Diagnostics, Incorporated and ARUP Laboratories, Inc. for diagnostic test products and services as well as QIAGEN NV for products for the research market and for sample preparation.

The company is based in Berlin and is represented by a wholly-owned subsidiary in Seattle, Washington. Additional information can be found at www.epigenomics.com.

About arvato services healthcare

arvato services healthcare is an internationally active integrated outsourcing services provider specializing in the healthcare and pharmaceutical industries. The company develops, implements and operates integrated distribution solutions tailored to the needs of its customers, their customers, physicians and patients. Using solid pharmaceutical and healthcare expertise, carefully crafted IT technologies and experience from many other fields, arvato services healthcare helps its customers to further optimize the distribution of their products. Customers benefit from comprehensive support along the entire order-to-cash cycle because arvato services reliably and efficiently manages all supply chain, customer relationship and financial processes. arvato services healthcare is a subsidiary of arvato AG, the international media, communications and logistics services provider.